BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 22, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

HER2 FISH pharmDx regulatory update

Dako received CE Mark approval in the EU for its HER2 FISH pharmDx to select patients...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >